Search Within

Solid Tumor Oncology Division

  1. "S. Karger AG"
Formats
  1. Meeting Abstract (137)
  2. Journal Article (20)
  3. Book Section (2)
  4. Conference Paper (1)
Groups
  1. Department of Medicine (160)
  2. Gastrointestinal Oncology Service (57)
  3. Thoracic Oncology (45)
  4. Genitourinary Oncology Service (35)
  5. Center for Pancreatic Cancer Research (17)
  6. Survivorship Research (14)

More Groups

People
  1. Alexander Drilon (23)
  2. Robert Motzer (23)
  3. Ghassan Abou-Alfa (18)
  4. Yelena Janjigian (12)
  5. Matthew Hellmann (9)
  6. Eileen O'Reilly (8)

More People

Years
  1. 2024 (10)
  2. 2023 (14)
  3. 2022 (25)
  4. 2021 (17)
  5. 2020 (30)
  6. 2019 (12)

More Years

Publications
  1. Oncology Research and Treatment (132)
  2. Oncology (9)
  3. Neuroendocrinology (5)
  4. Onkologie (5)
  5. Public Health Genomics (2)
  6. Basic Research in Urological Oncology (1)

More Publications

Publishers
  1. S. Karger AG (160)

Results (160)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Metastatic colorectal cancer: From improved survival to potential cure
    Journal Article

    Gallagher, David J.; Kemeny, Nancy
    Oncology (2010)

    Fulltext@MSK | Save
  • Sunitinib versus interferon-alpha for first-line treatment of metastatic renal cell carcinoma: Updated results and further prognostic factor analyses
    Meeting Abstract

    Grünwald, V.; Eberhardt, W.; Ringhoffer, M.; Jakse, G.; Motzer, R. J.
    Onkologie (2008)

    Fulltext@MSK | Save
  • Size matters - What can we learn from a small randomized trial?
    Journal Article

    Saltz, L.
    Onkologie (2007)

    Fulltext@MSK | Save
  • Oxaliplatin beim Kolorektalkarzinom: Neue Daten zu First-lineund adjuvanter Therapie
    Journal Article

    Goldberg, R. M.; Saltz, L.; Grem, J. L.; Lenz, H. J.
    Onkologie (2002)

    Fulltext@MSK | Save
  • The evolving role of gemcitabine in the management of breast cancer
    Journal Article

    Seidman, A. D.
    Oncology (2001)

    Fulltext@MSK | Save
  • Prostate cancer: Clinical considerations
    Book Section

    Hoffman, A.; Scher, H. I.
    In Luciani, L.; Debruyne, F. M. J.; Schalken, J. A. (Eds.) Basic Research in Urological Oncology (1996)

    Fulltext@MSK | Save
  • Taxol (paclitaxel) plus recombinant human granulocyte colony-stimulating factor in the treatment of metastatic breast cancer
    Conference Paper

    Seidman, A. D.; Norton, L.; Reichman, B. S.; Crown, J. P. A.; Yao, T. J.; Hakes, T. B.; Lebwohl, D. E.; Gilewski, T. A.; Hudis, C. A.; Surbone, A.; more...
    S. Karger AG (1994)

    Fulltext@MSK | Save
  • Deletions involving two distinct regions of 6q in B-cell non-Hodgkin lymphoma
    Meeting Abstract

    Gaidano, G.; Hauptschein, R. S.; Venkatraj, V. S.; Offit, K.; Rao, P. H.; Knowles, D. M.; Chaganti, R. S. K.; Dalla-Favera, R.
    Cytogenetics and Cell Genetics (1993)

    Fulltext@MSK | Save
  • Assessment of risk in metastatic testis carcinoma: Impact on treatment
    Journal Article

    Bajorin, D. F.; Geller, N. L.; Bosl, G. J.
    Urologia Internationalis (1991)

    Fulltext@MSK | Save
  • Phase II trial of mitoxantrone in advanced gastric cancer
    Journal Article

    Goldenberg, A.; Kelsen, D.; Benedetto, P.
    Oncology (1988)

    Fulltext@MSK | Save